XML 44 R35.htm IDEA: XBRL DOCUMENT v3.25.3

Collaborations, Licensing and Other Arrangements (Tables)

9 Months Ended

Sep. 30, 2025

Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]

Schedule of Total Revenue from Collaboration and Services

Revenue from collaborations and services were as follows (in thousands):

		Three Months Ended September 30,								Nine Months Ended September 30,
		2025				2024				2025				2024
UT CSA(1)		$	25,969			$	23,231			$	77,011			$	73,673
Amphastar co-promotion agreement			500				—				1,500				—
Cipla License and Distribution Agreement			37				37				110				110
Other			—				—				106				—
UT License Agreement			—				—				—				347
Total revenue from collaborations and services		$	26,506			$	23,268			$	78,727			$	74,130

_________________________

(1)Amounts consist of revenue recognized for Manufacturing Services to UT for the periods presented.

United Therapeutics Corporation

Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]

Schedule of Total Revenue from Collaboration and Services

Total revenue from UT was as follows (in thousands):

		Three Months Ended September 30,								Nine Months Ended September 30,
		2025				2024				2025				2024
Revenue from UT
Royalties(1)		$	33,319			$	27,083			$	94,552			$	75,326
UT CSA			25,969				23,231				77,011				73,673
UT License Agreement			—				—				—				347
Total revenue from UT		$	59,288			$	50,314			$	171,563			$	149,346

_________________________

(1)Amounts consist of royalties associated with the UT License Agreement. The contract assets related to the royalties are included in prepaid expense and other current assets in the condensed consolidated balance sheets.

UT CSA

Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]

Schedule of Total Revenue from Collaboration and Services

The portion of revenue related to each deliverable included in UT CSA revenue (in thousands) is as follows:

		Three Months Ended September 30,								Nine Months Ended September 30,
		2025				2024				2025				2024
UT CSA Revenue
Sale of product(1)		$	22,897				19,456				66,715				62,400
Recognition of previously deferred revenue			3,072				3,477				9,138				9,565
Other agreements			—				298				1,158				1,708
Total UT CSA revenue		$	25,969			$	23,231			$	77,011			$	73,673

_________________________

Sale of product included revenue related to fully reimbursable costs associated with product sales and other miscellaneous charges of $1.5 million and $5.8 million for the three and nine months ended September 30, 2024, and none in 2025

X

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 808
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479402/808-10-50-1

+ Details

Name:	us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 808
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479402/808-10-50-1

+ Details

Name:	us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Details

Name:	us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=mnkd_UnitedTherapeuticsCorporationMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=mnkd_UTCSAMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type: